Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Revette AC"'
Autor:
Carpenter K; Boston Combined Residency Program, Boston, Massachusetts, USA., Revette AC; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Scavotto M; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Mack JW; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA., Greenzang KA; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Aug; Vol. 71 (8), pp. e31093. Date of Electronic Publication: 2024 Jun 05.
Autor:
Ouchi K; Department of Emergency Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Emergency Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Serious Illness Care Program, Ariadne Labs, Boston, Massachusetts, USA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Prachanukool T; Department of Emergency Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Emergency Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Department of Emergency Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., Aaronson EL; Department of Emergency Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Department of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Lakin JR; Serious Illness Care Program, Ariadne Labs, Boston, Massachusetts, USA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Higuchi M; Division of Palliative Medicine, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Liu SW; Department of Emergency Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Department of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Kennedy M; Department of Emergency Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Department of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Revette AC; Survey and Data Management Core, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Chary AN; Department of Emergency Medicine, Baylor College of Medicine, Houston, Texas, USA., Kaithamattam J; Department of Emergency Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Lee B; Department of Emergency Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Neville TH; Division of Pulmonary and Critical Care, Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA., Hasdianda MA; Department of Emergency Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Emergency Medicine, Harvard Medical School, Boston, Massachusetts, USA., Sudore R; Division of Geriatrics, Department of Medicine, University of California, San Francisco, California, USA., Schonberg MA; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Tulsky JA; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Block SD; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Publikováno v:
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine [Acad Emerg Med] 2024 Jan; Vol. 31 (1), pp. 18-27. Date of Electronic Publication: 2023 Oct 29.
Autor:
Ramanadhan S; Harvard T.H. Chan School of Public Health, Boston, MA, USA. sramanadhan@hsph.harvard.edu., Salvia M; Harvard T.H. Chan School of Public Health, Boston, MA, USA., Hanby E; Annenberg School for Communication, University of Pennsylvania, Philadelphia, PA, USA., Revette AC; Dana-Farber Cancer Institute, Boston, MA, USA., Rivard MK; Harvard T.H. Chan School of Public Health, Boston, MA, USA., Scout NFN; LGBT Cancer Network, Providence, RI, USA., Applegate J; Ohio State University, Columbus, OH, USA., Gordon B; California LGBT Tobacco Education Partnership, San Francisco, CA, USA., Machado A; CenterLink, Inc, Fort Lauderdale, FL, USA., Lunn MR; Stanford University School of Medicine, Palo Alto, CA, USA., Obedin-Maliver J; Stanford University School of Medicine, Palo Alto, CA, USA., Potter J; Fenway Health, Boston, MA, USA.; Harvard Medical School, Boston, USA., Chen JT; Harvard T.H. Chan School of Public Health, Boston, MA, USA., Tan ASL; Annenberg School for Communication, University of Pennsylvania, Philadelphia, PA, USA.
Publikováno v:
Cancer causes & control : CCC [Cancer Causes Control] 2023 Aug; Vol. 34 (8), pp. 673-682. Date of Electronic Publication: 2023 May 09.
Autor:
Odai-Afotey A; Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA., Lederman RI; Survey and Qualitative Methods Core, Dana-Farber Cancer Institute, Boston, MA, USA., Ko NY; Section of Hematology and Medical Oncology, Department of Medicine, Boston Medical Center, Boston, MA, USA., Gagnon H; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA., Fikre T; Section of Hematology and Medical Oncology, Department of Medicine, Boston Medical Center, Boston, MA, USA., Gundersen DA; Survey and Qualitative Methods Core, Dana-Farber Cancer Institute, Boston, MA, USA., Revette AC; Survey and Qualitative Methods Core, Dana-Farber Cancer Institute, Boston, MA, USA., Hershman DL; Department of Medicine and Epidemiology, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, USA., Crew KD; Department of Medicine and Epidemiology, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, USA., Keating NL; Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.; Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA., Freedman RA; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. Rachel_freedman@dfci.harvard.edu.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. Rachel_freedman@dfci.harvard.edu.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Jul; Vol. 200 (1), pp. 127-137. Date of Electronic Publication: 2023 May 13.
Autor:
Clancy DD; Dana-Farber Cancer Institute, Boston, MA., Revette AC; Survey and Data Management Core, Dana-Farber Cancer Institute, Boston, MA.; Harvard School of Public Health, Boston, MA., Bahl NE; Dana-Farber Cancer Institute, Boston, MA., Ho KT; Dana-Farber Cancer Institute, Boston, MA., Manor B; Harvard Medical School, Boston, MA.; Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Roslindale, MA., Testa MA; Harvard School of Public Health, Boston, MA., Dieli-Conwright CM; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Hshieh T; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Roslindale, MA.; Brigham and Women's Hospital, Boston, MA., Driver JA; Harvard School of Public Health, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Geriatric Research, Education and Clinical Center and Geriatrics and Extended Care, VA Boston Healthcare System, Boston, MA., Abel GA; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Center for Bioethics, Harvard Medical School, Boston, MA., DuMontier C; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Geriatric Research, Education and Clinical Center and Geriatrics and Extended Care, VA Boston Healthcare System, Boston, MA.
Publikováno v:
JCO clinical cancer informatics [JCO Clin Cancer Inform] 2023 Apr; Vol. 7, pp. e2200171.
Autor:
Morris SE; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychiatry, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA., Revette AC; Survey and Data Management Core, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Brandoff DE; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA., Leiter RE; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA., Sannes TS; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychiatry, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA., Thomas JD; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Journal of palliative medicine [J Palliat Med] 2023 Apr; Vol. 26 (4), pp. 472-480. Date of Electronic Publication: 2022 Oct 03.
Autor:
Greenzang KA; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA., Scavotto ML; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Revette AC; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Schlegel SF; Division of Pediatric Endocrinology, Boston Children's Hospital, Boston, Massachusetts, USA., Silverman LB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA., Mack JW; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Mar; Vol. 70 (3), pp. e30198. Date of Electronic Publication: 2023 Jan 05.
Autor:
Merz A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Stevens SE; Washington University School of Medicine, St. Louis, Missouri, USA., Das PJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; University of Michigan Medical School, University of Michigan, Ann Arbor, USA., Avery M; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Revette AC; Survey and Data Management Core, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Wolfe J; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA., Feraco AM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Mar; Vol. 70 (3), pp. e30101. Date of Electronic Publication: 2022 Dec 22.
Autor:
Fenton ATHR; Dana Farber Cancer Institute, Boston, Massachusetts, USA. Electronic address: Annyt_fenton@dfci.harvard.edu., Fletcher KM; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Kizildag D; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Borstelmann NA; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Kessler D; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Cronin C; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Revette AC; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Wright AA; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Frank E; Dana Farber Cancer Institute, Boston, Massachusetts, USA., Enzinger AC; Dana Farber Cancer Institute, Boston, Massachusetts, USA.
Publikováno v:
Journal of pain and symptom management [J Pain Symptom Manage] 2023 Jan; Vol. 65 (1), pp. 16-25. Date of Electronic Publication: 2022 Oct 02.
Autor:
Freedman RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. rafreedman@partners.org.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. rafreedman@partners.org., Ko NY; Section of Hematology and Medical Oncology, Department of Medicine, Boston University School of Medicine, Boston, MA, USA., Lederman RI; Survey and Qualitative Methods Core, Dana-Farber Cancer Institute, Boston, MA, USA., Gagnon H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Fikre T; Section of Hematology and Medical Oncology, Department of Medicine, Boston University School of Medicine, Boston, MA, USA., Gundersen DA; Survey and Qualitative Methods Core, Dana-Farber Cancer Institute, Boston, MA, USA., Revette AC; Survey and Qualitative Methods Core, Dana-Farber Cancer Institute, Boston, MA, USA., Odai-Afotey A; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Kantor O; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Hershman DL; Department of Medicine and Epidemiology, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, USA., Crew KD; Department of Medicine and Epidemiology, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, USA., Keating NL; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Dec; Vol. 196 (3), pp. 623-633. Date of Electronic Publication: 2022 Oct 11.